Automation Opportunities for Medical Affairs EPISODE 1
In this first of 3 episodes, we will be meeting with an industry expert on Automation within the pharmaceutical industry.
In this first of 3 episodes, we will be meeting with an industry expert on Automation within the pharmaceutical industry.
This podcast, the 2nd in a 2-part series, discusses the What of the collaboration– the specific topics covered by phactMI, a nonprofit collaboration of Medical Information leaders.
MAPS speaks with Annemarie Clegg, CMO, OPEN Health, about the evolving role of Medical Affairs in providing context for payers, regulators and policy makers whose decisions can dramatically affect which patients can access industry innovations.
This podcast discusses the how and why this group of MI professionals, who are part of phactMI, a nonprofit collaboration of Medical Information leaders, came together and the lessons learned from their collaboration. Â
In this podcast, MAPS speaks with Renu Juneja, who started a medical writing fellowship program at Janssen, and with two of her former fellowship participants, Jennifer Lee and Lauren Brown.
This podcast details how Renu Juneja went from earning a PhD in the pharmaceutical industry to becoming a medical writer at Novo Nordisk.
This paper synthesizes the views of senior global Medical Affairs leaders to provide a unified vision for the future of Medical Affairs. As such, this document represents the first consensus position by executives in Medical Affairs of our evolving roles, activities, and value in society, industry, teams and as individuals (detailing each in turn). By 2030, Medical Affairs will solidify its transition from executional to strategic, and the function will come to represent the voice of the patient within industry. We will not only disseminate evidence but also lead evidence generation activities that inform the real-world use of marketed and emerging treatments. Also in this time frame, we will solidify the role of Medical Affairs as industry’s external earpiece, gleaning insights from our interactions with the health care ecosystem that drive understanding of patient, payer, and provider needs and opinions. Throughout this evolution, the true north of Medical Affairs remains the same: to ensure that our science and technologies benefit patients.
At the MAPS 2022 Global Annual Meeting, we sat down with Riad Dirani, Vice President of Global Health Economics and Outcomes Research at Teva Pharmaceuticals, and Omar Dabbous, Vice President of Global Health Economics and Outcomes Research and Real World Evidence at AveXis to chat about the structure and activities of HEOR within Medical Affairs.
MAPS speaks with Tim Mikhelashvili and Riaz Abbas about innovative approaches to compliant patient education including collaborations with patient associations, peer navigators and the emerging use of social media.
MAPS members represent the full range of Medical Affairs professionals, from those leading or working in large organizations, to those tasked with starting a Medical Affairs function at startup or emerging organizations. Here, MAPS speaks with Lobna Salem, Regional Chief Medical officer Developed Markets& Japan Australia and New Zealand at Viatris, about the process of building Medical Affairs from scratch.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.